AUG 20, 2026 · PHASE 3 TRIAL
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure
ClinicalTrials.gov
This is a Phase 3 trial registry record with no results posted; the study is active but not recruiting, and outcomes have not yet been reported in this source.
Reported
Planned enrollment776
Study phasePHASE3
Primary outcome measure 1Progression-free Survival (PFS) according t…